Pharmacogenetic aspects in the metabolism of psychotropic drugs: Pharmacokinetic and clinical implications
- 20 February 1994
- journal article
- review article
- Published by Elsevier in Pharmacological Research
- Vol. 29 (2) , 121-137
- https://doi.org/10.1016/1043-6618(94)80036-7
Abstract
No abstract availableThis publication has 92 references indexed in Scilit:
- Genetically variable metabolism of antidepressants and neuroleptic drugs in manPharmacogenetics, 1993
- P450 EnzymesClinical Pharmacokinetics, 1992
- The P450 Superfamily: Update on New Sequences, Gene Mapping, and Recommended NomenclatureDNA and Cell Biology, 1991
- Formation of Active Metabolites of Psychotropic DrugsClinical Pharmacokinetics, 1990
- N-acetyltransferasePharmacology & Therapeutics, 1989
- Human cytochromes P-450Xenobiotica, 1984
- Defective N-oxidation of sparteine in man: A new pharmacogenetic defectEuropean Journal of Clinical Pharmacology, 1979
- POLYMORPHIC HYDROXYLATION OF DEBRISOQUINE IN MANThe Lancet, 1977
- Insufficient parahydroxylation as a cause of diphenylhydantoin toxicityNeurology, 1964
- Genetic Control of Isoniazid Metabolism in ManBMJ, 1960